Test home brain stimulation safety
- Trial ID
- NCT06804668
- Official Title
- Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease
- Goal
- Test home brain stimulation safety
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Brigham and Women's Hospital
- Study Type
- INTERVENTIONAL
- Enrollment
- 6 participants
- Conditions
- Parkinson Disease
- Interventions
- tDCS
Plain-Language Summary
The goal is to see whether transcranial direct current stimulation can be delivered safely and reliably at home with remote supervision for people with Parkinson's. The approach uses tDCS, a small device that sends a weak, constant electrical current through scalp electrodes to gently increase or decrease brain excitability in areas tied to movement and thinking, and it would be used alongside usual medications rather than replacing levodopa. This is a small pilot enrolling about six people with Parkinson's aged 40 to 70 who can use a computer for video calls and follow remote setup instructions. People with moderate or severe depression, cranial metal implants or pacemakers, epilepsy or prior stroke, active substance abuse, or who cannot independently adjust the electrode cap are excluded.
Locations
- Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women's Hospital, Boston, Massachusetts, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying tDCS. The goal is to see whether transcranial direct current stimulation can be delivered safely and reliably at home with remote supervision for people with Parkinson's. The approach uses tDCS, a small device that sends a weak, constant electrical current through scalp electrodes to gently increase or decrease brain excitability in areas tied to movement and thinking, and it would be used alongside usual medications rather than replacing levodopa. This is a small pilot enrolling about six people with Parkinson's aged 40 to 70 who can use a computer for video calls and follow remote setup instructions. People with moderate or severe depression, cranial metal implants or pacemakers, epilepsy or prior stroke, active substance abuse, or who cannot independently adjust the electrode cap are excluded.
- Who can participate?
- Participants must be between 40 Years and 70 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 6 months.